Navigation Links
HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)
Date:6/1/2009

it is live and stimulates a broad range of immune responses, LAIV may offer some cross-protection against circulating flu strains that are "drifted" - meaning they are very closely-related but not perfectly matched to the flu strains in the vaccine.

As a needle-free nasal spray, LAIV is well suited to facilitate mass vaccination, and has been widely used for school-based vaccinations and to help protect active-duty military personnel.

While MedImmune is committed to supporting global efforts to help protect individuals against the Novel Influenza A (H1N1) virus, its vaccine technology is currently only licensed in the United States. MedImmune is willing to make additional vaccine available to other governments if any capacity remains after fulfilling obligations to the U.S. government, assuming that necessary regulatory approval can be obtained.

Seasonal FluMist(R) on Track to Begin Shipping in August

MedImmune believes that the best way to help protect all eligible age groups against seasonal influenza is to vaccinate prior to and during the back-to-school period. The CDC's Advisory Committee on Immunization Practices (ACIP) recommends influenza vaccination for all age groups as soon as seasonal vaccine is available each year. MedImmune plans to begin shipping the first of approximately 10 million doses of seasonal FluMist(R) (Influenza Virus Vaccine Live, Intranasal) to health care providers in August. This early availability of vaccine significantly widens the window of opportunity to vaccinate more eligible individuals and improve seasonal influenza vaccination rates, as patients seeing their providers for routine office visits can be vaccinated without waiting for the rush of fall vaccination clinics.

About Seasonal FluMist

FluMist(R) (Influenza Virus Vaccine Live, Intranasal) is a vaccine indicated for active immunization of individuals
'/>"/>

SOURCE MedImmune
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting
2. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
3. Best of Show Awards Winners Named at Bio-IT World Conference & Expo
4. Bio-IT World Announces the Winners of its 2009 Best Practices Awards Program
5. Moleac Named Singapore Entrepreneurial Company of the Year at the Frost & Sullivan Excellence in Healthcare Awards
6. American Geographical Society awards honor Henson, Smith on April 15 at UD
7. Frost & Sullivan to Present the 2009 Excellence in Medical Technologies & Life Sciences Awards
8. Three Firms, Two Training Programs Garner Greater Baltimore Committees 2009 Bioscience Awards
9. Greater Baltimore Committee to Announce Winners of 2009 Maryland Bioscience Awards at Ceremonies on March 12
10. EPA Awards Lovelace Respiratory Research Institute $500,000 for Air Quality Research
11. Weed Science Society of America Announces Winners in Annual Scientific Awards Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... investment bank KTA Capital,s client Neuren Pharm...convertible note private placement with a U.S. ins...anged by KTA Capital as Neuren,s exclusive placeme...ew York (PRWEB) November 23, 2009 -- The independe...t;KTA Capital") has announced that its client...
(Date:11/24/2009)...wire/--TwomoreprestigiousuniversitieshavejoinedBio...reerssiteforlifescienceprofessionals. ,, Northw...ard,joining28othermajorlifesciencetrainingInstitut...isonlyforpost-graduatesinthelifesciences.Whilether...BioCareerCenteristheonlyonethatserveslifesciencepo...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--DowAgroSciencesCanadaan...ivisionofThompsonsLimitedofBlenheim,Ontario.Theadd...,currentseedsbusinessasthecompanyanticipatestheint...ncesHerbicideTolerantTraitTechnologyincornin2012.T..., "Thisacquisitionbringstogethertwostrongprogress...
(Date:11/24/2009)...RNewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq:...heNasdaqStockMarketthattradinginthecompany,scommon...-NSEwillbefiledwiththe,SecuritiesandExchangeCommis...gonNasdaq,unlessthecompanyfilesanappealtotheNasdaq...anappeal,which,willstaythesuspensionanddelistingth...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...g a 5-ASA Medicine, BASINGSTOKE, England and PHIL... plc (LSE: SHP, NASDAQ: SHPGY), the global special...-promotion agreement with,TAP Pharmaceutical Produ...echnology, indicated for the induction of remissio...tive colitis (UC). This three year agreement,is fo...
...ration (Nasdaq: PRXL ) will release Third Quarter...April 23, 2008 after the close of the stock,market...website at, http://www.parexel.com and on the PR ... PAREXEL will host a conference call and live web... to discuss the results. To access the webcast,vis...
...With CyberKnife System to Date, SUNNYVALE, Calif.... a global leader in the field of radiosurgery,anno...Knife centers,worldwide are now treating lung canc...tem*. The number of lung cancer patients is growin...viduals receiving,CyberKnife treatments to date., ...
Other Biology Technology:Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis 2Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis 3Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis 4Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis 5PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call 2CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 2CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 3CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 4
(Date:11/24/2009)...us Research Institute (LRI) today named 12 new gra...million, recognize innovative work across a broad ...their creativity, novelty, and potential to drive ... and cure the complex disease of systemic lupus. ,...lupus researchers across the nation and include in...
(Date:11/24/2009)...science is opening new doors to understanding how ... hearing of a marine mammal or if they hear it at...X-ray scanners that NASA uses to detect flaws in t...now allowing scientists to peek inside the giant h...hree-dimensional replicas of a whale,s hearing ana...
(Date:11/24/2009)...sts have crystallised a protein that may help gut ...rotein could be used by probiotic producers to ide...t to people. , "Probiotics need to interact with ...and if they attach to surfaces in the gut they are...their activity," says Dr Nathalie Juge from the In...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Rocket science leads to new whale discovery 2A sticky solution for identifying effective probiotics 2Red Cross Participates in September 11th National Day of Service and Remembrance 56694 1Red Cross Participates in September 11th National Day of Service and Remembrance 56694 2Select Medical Holdings Corporation Commences Initial Public Offering of Common Stock 56690 1Select Medical Holdings Corporation Commences Initial Public Offering of Common Stock 56690 2In Letter to President TPC Highlights Foundation Grants in Health 56686 1In Letter to President TPC Highlights Foundation Grants in Health 56686 2In Letter to President TPC Highlights Foundation Grants in Health 56686 3
...blood clot-dissolving medication that is administe...ttack may help to reduce the risk of amputation fo... the June issue of Archives of Surgery, one of the... remained essentially the same for the past 25 yea...icle. “Today, traditional therapy consists of tiss...
...iversity have used genetic modification to success...owing that it’s possible to create miniature trees...eral years of growth may range anywhere from 50 fe...cept” that tree height can be readily controlled b...r to a wide variety of new products for the orname...
...on, a University of Iowa anthropologist and his co...m a "pygmy-sized" giant panda -- the earliest-know...th China some two million years ago. , The ancesto...panda, says Russell Ciochon, UI professor of anthr...thor of an article published in the June 18-22 onl...
Other Biology News:Clot-dissolving agent may be beneficial in treatment of severe frostbite 2Researchers demonstrate way to control tree height 2Researchers demonstrate way to control tree height 3UI anthropologist, colleagues discover remains of earliest giant panda 2
Multidrop DW (Deep Well) (220-240 V) from Thermo Scientific
ma. plate stack height 70mm from Thermo Scientific
MBS Satellite Thermal Cycler from Thermo Scientific
801 Rotor System with 305/315, 6 50 ml Falcon/Corning from Thermo Scientific
Biology Products: